VERTANICAL’s VER-01 gains FDA breakthrough status for low back pain

VERTANICAL is undertaking a pivotal Phase III US trial for future FDA submission. Credit: Gorodenkoff / Shutterstock.com.



  • FDA VERTANICAL’s VER-01